ストックスクリーナーアプリを入手
21.54
3.75%
-0.84
前日終値:
$22.38
開ける：
$22.29
24時間の取引高:
51,837
Relative Volume:
0.53
時価総額：
$235.76M
収益：
$56.54M
当期純損益:
$-30.70M
株価収益率:
-55.23
EPS:
-0.39
ネットキャッシュフロー:
$-31.05M
1週間 パフォーマンス:
-10.03%
1か月 パフォーマンス:
-2.89%
6か月 パフォーマンス:
+65.69%
1年 パフォーマンス:
+56.09%
1日の値動き範囲:
$21.23
$22.30
1週間の範囲:
$20.50
$24.95
52週間の値動き範囲:
$10.00
$28.42
Cidara Therapeutics Inc Stock (CDTX) Company Profile
名前
Cidara Therapeutics Inc
セクター
電話
858-752-6170
住所
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
CDTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
21.54 | 235.76M | 56.54M | -30.70M | -31.05M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-27 | 再開されました | Cantor Fitzgerald | Overweight |
| 2024-12-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-11-08 | 開始されました | Guggenheim | Buy |
| 2024-08-14 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | 再開されました | H.C. Wainwright | Buy |
| 2021-09-22 | アップグレード | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | 開始されました | Aegis Capital | Buy |
| 2019-09-04 | アップグレード | Wedbush | Neutral → Outperform |
| 2018-07-26 | 開始されました | Citigroup | Buy |
| 2017-04-21 | 開始されました | Raymond James | Strong Buy |
| 2017-04-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-04-12 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-04-11 | 再開されました | Wedbush | Outperform |
| 2017-02-22 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-02-22 | アップグレード | WBB Securities | Sell → Hold |
| 2016-12-21 | 再開されました | Leerink Partners | Outperform |
| 2016-12-19 | 開始されました | H.C. Wainwright | Buy |
| 2016-09-23 | ダウングレード | WBB Securities | Hold → Sell |
| 2015-10-09 | アップグレード | WBB Securities | Sell → Hold |
| 2015-05-11 | 開始されました | Jefferies | Buy |
| 2015-05-11 | 開始されました | Leerink Partners | Outperform |
| 2015-05-11 | 開始されました | Needham | Buy |
| 2015-05-11 | 開始されました | Wedbush | Outperform |
| 2015-04-23 | 開始されました | WBB Securities | Sell |
すべてを表示
Cidara Therapeutics Inc (CDTX) 最新ニュース
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Significant Increase in Short Interest - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Bourla becomes chair of PhRMA - BioCentury
Invasive Candidiasis Market to Reach New Heights in Growth - openPR
Brokerages Set Cidara Therapeutics, Inc. (NASDAQ:CDTX) Price Target at $32.20 - Defense World
Cidara Therapeutics, Inc. Announces Chief Financial Officer Changes, Effective February 24, 2025 - Marketscreener.com
Cidara CFO steps down, new appointment announced By Investing.com - Investing.com South Africa
Cidara Therapeutics Announces Appointment Of Frank Karbe As Chief Financial Officer - Marketscreener.com
Cidara Therapeutics Announces CFO Transition - TipRanks
Cidara CFO steps down, new appointment announced - Investing.com
Cidara Therapeutics appoints new CFO amid flu drug trials - Investing.com India
Cidara Therapeutics Announces Appointment of Frank Karbe as Chief Financial Officer - GlobeNewswire
Strategic CFO Hire: $4B Deal Architect Frank Karbe Joins Cidara as Growth Plans Accelerate - StockTitan
Cidara Therapeutics (NASDAQ:CDTX) Stock Price Crosses Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Bullish On Cidara Therapeutics As It Doubles Down On CD388 For Universal Flu Prevention - Seeking Alpha
(CDTX) Trading Signals - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Up 113.6% in January - MarketBeat
Cidara Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewswire
Inside Cidara's Next Move: CEO Jeffrey Stein Takes Center Stage at Elite Biotech Conference - StockTitan
Long Term Trading Analysis for (CDTX) - Stock Traders Daily
Cantor Fitzgerald raises Cidara stock to Overweight - MSN
Cidara Therapeutics’ (CDTX) “Overweight” Rating Reaffirmed at Cantor Fitzgerald - Defense World
Cantor Fitzgerald raises Cidara stock to Overweight By Investing.com - Investing.com Canada
Cidara Therapeutics (NASDAQ:CDTX) Receives "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Cidara Therapeutics (NASDAQ:CDTX) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives $32.20 Consensus Price Target from Analysts - MarketBeat
Contrasting Cidara Therapeutics (NASDAQ:CDTX) and Kodiak Sciences (NASDAQ:KOD) - Defense World
Here’s Why Cidara Therapeutics, Inc. (CDTX) Is Skyrocketing - MSN
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Short Interest Update - MarketBeat
Why These 24 Stocks Are Skyrocketing - Insider Monkey
Geode Capital Management LLC Buys 9,771 Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World
(CDTX) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cidara Therapeutics (NASDAQ:CDTX) Shares Cross Above 50 Day Moving AverageTime to Sell? - MarketBeat
Cidara Therapeutics announces board changes, CMO separation - Investing.com
Cidara Therapeutics Announces Leadership Changes and Appointments - MSN
Cidara Therapeutics, Inc. Announces Management Changes - Marketscreener.com
Cidara Therapeutics Inc (CDTX) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):